You are viewing issue# 983

With AbbVie-Allergan decision, Simons draws the line, blasts Dems

Perhaps more than in any other case since Joe Simons became chairman of the Federal Trade Commission, the 3-2 decision approving drugmaker AbbVie’s $63 billion buyout of rival Allergan reveals his unhappiness with the dissents of his Democratic colleagues.


Read More

Lawmakers, activists lay groundwork for antitrust policy shifts after election

Wait until next year.

Debate persists over impact of FTC’s much-touted hearings

It’s been almost two years since Federal Trade Commission Chairman Joe Simons announced with some fanfare a series of hearings to review and perhaps even re-think the agency’s approach to antitrust...

Simons gets warm Capitol Hill reception, but some chairs haven’t been so lucky

Congressional Democrats may loathe President Donald Trump, but at least when it comes to consumer protection issues, they appear to like his Federal Trade Commission chairman.

A robocall win for Feds as Covid-19 fraud calls surge

The Federal Trade Commission won a preliminary injunction against an Arizona firm for facilitating foreign robocallers who were impersonating US government officials.

Navigating hot-button issues with top privacy advocate Polonetsky

Privacy advocate Jules Polonetsky has made a career out of listening. It’s a skill he acquired working in local New York politics, representing working-class neighborhoods such as Coney Island and...

Neil Averitt commentary: Questions about Amazon’s spying? The answers lie within the FTC Act

Amazon’s aggressive practices have led to many antitrust complaints from its business partners. The latest one accuses the tech conglomerate of spying on third-party companies that sell through its...

Coronavirus pandemic exposes limits of sectoral privacy regulation

Facebook launches self-regulatory ‘experiment’ with autonomous Oversight Board

Ex-Bumble Bee CEO facing potential record sentence for antitrust case

People

Calendar